OpenVSafe by OpenVAERS
Search V-safe

6SQ-11832-69133

2 vaccinations 3 coded responses 3 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
934 / CA
Registered
2021-06-09
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-03-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-06
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-09
    Registered in v-safe
  4. 2021-07-06
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Menstruation delayed, Palpitations — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Severe fatigue. Heart palpitations. Missed periods
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-07-06
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  6. 2021-07-12
  7. 2021-10-05
    Survey response — 6 months, dose 2
    MedDRA: Disturbance in attention, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Tired, hard to concentrate
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-04-06
    Survey response — 12 months, dose 2
    MedDRA: Abdominal pain, Ovarian cyst — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Abdominal pain and ovarian cyst
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-04-06
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  10. 2022-04-14

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Pfizer-BioNTech
22021-04-06Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-07-06 Unsuccessful
2022-04-06 Unsuccessful

Free text

Release 9 — 3 months, dose 2

2021-07-06

Symptoms: Severe fatigue. Heart palpitations. Missed periods

Release 10 — 6 months, dose 2

2021-10-05

Symptoms: Tired, hard to concentrate

Release 11 — 12 months, dose 2

2022-04-06

Symptoms: Abdominal pain and ovarian cyst

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDDisturbance in attention · · ✓
SDFatigue ✓ ✓ ✓
SDMenstruation delayed ✓ ✓ ✓
SDOvarian cyst · · ✓
SDPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release